.RESEARCH FEATURE.06 August 2024.
A sizable randomized controlled test along with cisgender females highlights the challenges of faithfulness to a day-to-day oral preexposure prevention routine and also demonstrates that twice-yearly shot of lenacapavir can preserve successful HIV prevention degrees over 6 months.